We were thrilled to welcome Nobel laureate and member of our Scientific Advisory Board Venki Ramakrishnan to @IsomorphicLabs in London this week. Our Structural Bioinformatics team leader Adrian Stecula led a riveting fireside chat that explored how diverse perspectives drive innovation and the challenges of identifying true breakthroughs amid technological revolutions. ...

Our CTO @SergeiIakhnin visited 10 Downing Street to join the first OpenBind consortium meeting hosted by the UK government. Read more here: https://t.co/bRwArIHgFeSergei Yakneen (@SergeiIakhnin):Enjoyed kicking off the OpenBind consortium with members of industry and academia and hosted by UK govt at 10 Downing st. OpenBind will create a huge public data set of protein-ligand structures and binding affinities for AI in drug discovery and @IsomorphicLabs is helping drive https://t.co/IyaCzqnfO2 ...

Catch our team, @_lychrel, @riceasphait, Georgia Nicholson, @benrozemberczki, Caroline Low, Matthew Brown, Lexi Walker, Gino Cassella, Jennifer Coughlin, Ruth Potts and @VStimper at ICML in Vancouver, Canada between 13-19 July to find out more about what we’re working on at Isomorphic Labs, and learn about the opportunities to join the team.Register to connect with us here: https://t.co/nJaWaAq0Xk#ICML2025 ...

The establishment of our US presence and the appointment of Dr. Ben Wolf as CMO mark our next chapter as we continue progressing our work to transform drug design and discovery with AI.Read more from Ben here: https://t.co/UNfAVkKnSM https://t.co/NpSIR0CQOx ...

We're excited to welcome Dr. Ben Wolf, M.D., Ph.D., as our new Chief Medical Officer at Isomorphic Labs!Dr. Wolf brings nearly 20 years of biopharmaceutical experience to the team, and will be based in our new Cambridge, Massachusetts location as we advance therapeutic programs into the clinic using machine learning to transform drug design.Read more on our website: https://t.co/uyMue4UqRv ...

RT Google DeepMind (@GoogleDeepMind)The future of drug discovery isn't just about AI; it's about how AI empowers human experts. 🥼Join @_rebecca_paul and @maxjaderberg from @IsomorphicLabs, as they share their insights with @fryrsquared on leveraging AI agents to explore vast molecular spaces.See their discussion ↓ ...

Our President, Colin Murdoch, is attending @VivaTech 2025 in Paris to speak about the potential of AI for drug discovery and share more about the groundbreaking work we do at Isomorphic Labs.Be sure to catch Colin at his two sessions:June 12 | AI Drug Discovery panel discussion alongside @kpowgerade, Vice President, Healthcare and Life Sciences, NVIDIA, moderated by Benoît Georges from Les Echos (2.50 - 3.15 CEST)June 13 | Fireside chat with @Melissahei from the FT (10.30 - 10.55 CEST)Find out more about wh ...

Read more here:https://t.co/jjijR4h6cg ...

We are thrilled to support the UK’s new #OpenBind consortium, a government-backed initiative to create the world’s largest open dataset for AI drug discovery. ...

RT Google DeepMind (@GoogleDeepMind)The ambition at @IsomorphicLabs is immense – they’re rethinking drug discovery from the ground up, using AI. 💊Join Head of Medicinal Drug Design @_rebecca_paul & Chief AI Officer @maxjaderberg as they share the possibilities of AI in tackling disease with host @fryrsquared.Watch their conversation ↓Timecodes:00:00 Intro02:11 AI & Disease05:30 AI in Biology06:51 Molecules and Proteins12:05 AlphaFold 314:40 Demo16:20 Human-AI collaboration24:30 Drug Design Challenges39:00 B ...